title: Review article: volume expansion in patients with cirrhosis.
abstract: Adequate size and distribution of the circulating medium are important for cardiovascular function, tissue oxygenation, and fluid homoeostasis. Patients with cirrhosis have cardiovascular dysfunction with a hyperkinetic systemic circulation, abnormal distribution of the blood volume, vasodilation with low systemic vascular resistance, increased whole-body vascular compliance, and increased arterial compliance. The effectiveness and temporal relations of plasma/blood volume expansion depend highly on the type of load (water, saline, oncotic material, red blood cells). Patients with cirrhosis respond in some aspects differently from healthy subjects, owing to their disturbed circulatory function and neurohormonal activation. Thus the increase in cardiac output and suppression of the renin-angiotensin-aldosterone system and sympathetic nervous system during volume expansion may be somewhat blunted, and in advanced cirrhosis, especially the non-central parts of the circulation, including the splanchnic blood volume, are expanded by a volume load. Infusion of oncotic material (preferably albumin) is important in the prevention of post-paracentesis circulatory dysfunction. In conclusion, volume expansion in advanced cirrhosis is qualitatively and quantitatively different from that of healthy subjects, and in those with early cirrhosis. Timely handling is essential, but difficult as it is a balance between the risks of excess extravascular volume loading and further circulatory dysfunction in these patients with a hyperdynamic, but hyporeactive, circulation.
authors.affiliation: Department of linical Physiology 239, Hvidovre Hospital, University of Copenhagen, Denmark. jens.h.henriksen@hh.hosp.dk
authors.forename: J H
authors.initials: JH
authors.lastname: Henriksen
authors.forename: M
authors.initials: M
authors.lastname: Kiszka-Kanowitz
authors.forename: F
authors.initials: F
authors.lastname: Bendtsen
mesh_terms: D001810:Blood Volume; D005440:Fluid Therapy / Q000379:methods*; D006439:Hemodynamics; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology / Q000628:therapy*; D010952:Plasma Substitutes / Q000627:therapeutic use; D012709:Serum Albumin / Q000627:therapeutic use
chemical_list: D010952:Plasma Substitutes; D012709:Serum Albumin